Clin Mol Hepatol.
2024 Apr;30(2):150-153. 10.3350/cmh.2024.0116.
Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization
- Affiliations
-
- 1Middle East Liver Diseases Center, Tehran, Iran
- 2Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 3Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 4Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- KMID: 2554416
- DOI: http://doi.org/10.3350/cmh.2024.0116
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Reply to correspondence on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”
- Significance of serum complement levels in chronic liver disease and hepatocellular carcinoma in liver cirrhosis
- Basic Concepts of a Mendelian Randomization Approach
- Mendelian Randomization Studies in Atherosclerotic Cardiovascular Diseases
- Roles of the complement system in alcohol-induced liver disease
